Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Moderna, Inc. - Common Stock
(NQ:
MRNA
)
25.70
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 12, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Moderna, Inc. - Common Stock
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
99
100
Next >
This Is What Whales Are Betting On Moderna
December 21, 2023
Via
Benzinga
Pfizer's chaotic year wraps up with plunging stock, grim guidance
December 21, 2023
Pfizer's tumultuous 2023 included a 41.84% stock plunge as revenue from Covid drugs fell. Disappointing 2024 guidance resulted in analysts slashing targets.
Via
MarketBeat
Exposures
COVID-19
Moderna to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 20, 2023
Via
ACCESSWIRE
COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs
December 20, 2023
COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines launched in 2020, will close on 31 December 2023.&n
Via
Benzinga
Exposures
COVID-19
Long-Term, Organic Revenue Growth Is A Key To Investment Success
December 20, 2023
Revenue growth is probably the easiest of the 4 check boxes to quantify. Anyone can pull up their broker's research pages, or Yahoo Finance, and look at the past 3 or 5 years of revenue.
Via
Talk Markets
$100 Invested In This Stock 5 Years Ago Would Be Worth $500 Today
December 18, 2023
Via
Benzinga
Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks This Year?
December 20, 2023
One retail chain may have the clearest path to market-beating upside from here.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
QQQ And QQQM ETFs Top Gainers And Laggards Of 2023
December 20, 2023
This article will look at the top gainers and laggards of the two popular ETFs, which have over $17 billion and $223 billion assets, respectively. The two funds are similar, with the only difference...
Via
Talk Markets
Topics
ETFs
Don’t Waste Another Minute: Dump These 3 F-Rated Stocks Now
December 19, 2023
Avoid these f-rated stocks like the plague in order to help keep your portfolio squeaky clean in the new year.
Via
InvestorPlace
Tech Stocks Set New All-Time High, Small Caps On Fire As Wall Street Bulls Run Wild: What's Driving Markets Tuesday?
December 19, 2023
Tuesday, December 19, 2023, stands now as a remarkable day in Wall Street’s history, as the technology stocks of the Nasdaq 100 mark a significant milestone, surging to new highs after a hiatus of 758...
Via
Benzinga
3 Stocks Down 30% or More This Year That Wall Street Expects to Skyrocket in 2024
December 18, 2023
Analysts think these beaten-down stocks could rebound strongly in the new year.
Via
The Motley Fool
Moderna Just Took a Step Closer to Its Product Launch Goal. Is the Stock a Buy?
December 18, 2023
Moderna's personalized cancer vaccine candidate just delivered excellent clinical trial results.
Via
The Motley Fool
Moderna Entering Weekly Bluebox Support Area
December 17, 2023
Moderna, Inc. is an US American pharmaceutical and biotechnology company. Founded in 2010 and headquartered in Cambridge, Massachusetts, USA, it is a part of NASDAQ100 and S&P500 indices.
Via
Talk Markets
3 S&P 500 Stocks That Are About to Get Absolutely Crushed
December 16, 2023
Investors should be careful with these securities, each of which has been slumping and could fall further in the year ahead.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Contaminated Vaccines: FDA Reportedly Finds Cleaning And Expiry Lapses At Moderna's Massachusetts Facility
December 16, 2023
The U.S. Food and Drug Administration (FDA) identified several quality control issues at the primary manufacturing facility of Moderna Inc. (NASDAQ: MRNA)
Via
Benzinga
Exposures
Product Safety
Barron's Weekend Stock Picks: Nokia, Roku, Nvidia And Moderna's Latest Cancer Treatment Trial
December 16, 2023
Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read.
Via
Benzinga
Stock Market Rally Surges To 2023 Highs As Fed Pivots Toward Rate Cuts: Weekly Review
December 15, 2023
The Dow hit a record high while the S&P 500 and Nasdaq set 2023 bests.
Via
Investor's Business Daily
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
3 No-Brainer Healthcare Stocks to Buy Right Now
December 15, 2023
These players have what it takes to boost your portfolio over time.
Via
The Motley Fool
Fear & Greed Index Remains In 'Greed' Zone Following Economic Reports; Dow Records New High
December 15, 2023
The CNN Money Fear and Greed index showed some easing in overall market sentiment, but the index remained in the "Greed" zone on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Costco, Pfizer, Moderna, Lennar Corp, Tesla: Why These 5 Stocks Are On Investors' Radars Today
December 14, 2023
The stock market witnessed a notable surge today, with the Dow Jones rising 0.43% to 37,248.35 and the S&P 500 gaining 0.26% to 4,719.55.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
MRNA Stock Surges as Moderna Teams Up With Merck to Fight Cancer
December 14, 2023
Moderna is in focus after reporting positive results for its cancer treatment today, with MRNA stock surging more than 9%.
Via
InvestorPlace
Moderna CEO Highlights Promising Cancer Vaccine Data: 'Think About The Number Of Lives That Can Be Impacted'
December 14, 2023
Moderna, Inc. (NASDAQ: MRNA) CEO Stéphane Bancel appeared on CNBC's "Squawk Box" Thursday to discuss the company's promising new cancer vaccine developed in
Via
Benzinga
Nasdaq Turns Lower; US Retail Sales Top Estimates
December 14, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning lower on Thursday. The Dow traded up 0.04% to 37,105.00 while the NASDAQ fell 0.44% to 14,669.25. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
US Stocks Eye 7-Day Winning Streak As Mortgage Rates Fall Below 7%, Yields Tumble: What's Driving Markets Thursday?
December 14, 2023
It’s shaping up to be a positive Thursday on Wall Street, with risk sentiment remaining robust after the Federal Reserve effectively opened the door to rate cuts in 2024.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data For MRNA-1345, The Company’s Investigational Respiratory Syncytial Virus (RSV) Vaccine
December 14, 2023
Via
ACCESSWIRE
Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 14, 2023
Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales...
Via
Benzinga
Why Are Bank Stocks Up Today?
December 14, 2023
Bank stocks are up today and investors wonder why have come to the right place as we have a detailed explanation for the rally!
Via
InvestorPlace
Jabil Posts Upbeat Earnings, Joins Moderna, Rivian Automotive And Other Big Stocks Moving Higher On Thursday
December 14, 2023
U.S. stocks traded higher, with the Nasdaq Composite gaining around 75 points on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is SOFI Stock Up Today?
December 14, 2023
SoFi Technologies stock is up on Thursday as investors celebrate news that the Federal Reserve won't increase interest rates.
Via
InvestorPlace
Topics
Economy
Exposures
Interest Rates
Opendoor (OPEN) Stock Jumps on Analyst Upgrade
December 14, 2023
Opendoor Technologies stock is rising higher on Thursday as investors in OPEN shares react to an upgrade from Keefe, Bruyette & Woods.
Via
InvestorPlace
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.